Impact of Flumazenil on the Emergence Delirium

PHASE4CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

March 5, 2023

Primary Completion Date

August 11, 2023

Study Completion Date

August 11, 2023

Conditions
Anesthesia, General
Interventions
DRUG

Flumazenil

After cessation of remimazolam infusion, flumazenil 0.2 mg is administered intravenously over 15 seconds. If consciousness is not adequately restored within 3-5 minutes, a second dose of 0.1 mg intravenously over 15 seconds is administered. If necessary, 0.1 mg may be administered repeatedly at 3-5 minute intervals, and the maximum dose of 1 mg should not be exceeded.

Trial Locations (1)

08308

Korea University Guro Hospital, Seoul

All Listed Sponsors
lead

Korea University Guro Hospital

OTHER